Pfizer vaccine for kids under 5: FDA authorization paused for data
The FDA will wait to take up Pfizer's request until data becomes available on a third vaccine dose for children under 5, likely in early April.
Stay updated with breaking news from Their Future. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA will wait to take up Pfizer's request until data becomes available on a third vaccine dose for children under 5, likely in early April.
The FDA will wait to take up Pfizer's request until data becomes available on a third vaccine dose for children under 5, likely in early April.
The FDA will wait to take up Pfizer's request until data becomes available on a third vaccine dose for children under 5, likely in early April.
About 250 doctors signed a letter calling on the FDA to 'cut the red tape' and demanding kids under 5 get 'urgent access' to COVID-19 vaccines.
Laboratory tests and physical examinations of long Covid patients may show nothing out of the ordinary.